MedPath

Cognitive-behavioral Therapy for Generalized Anxiety Disorder in Primary Care

Not Applicable
Completed
Conditions
Generalized Anxiety Disorder
Registration Number
NCT03621371
Lead Sponsor
Karolinska Institutet
Brief Summary

The feasibilty and preliminary comparative effectiveness of two methods of cognitive-behavioral therapy - metacognitive therapy and intolerance of uncertainty therapy - for primary care patients with generalized anxiety disorder is investigated in a pilot study using a randomized controlled design. Purpose of the study is to examine the feasibility of a full-scale randomized controlled trial. Research questions primarily concern recruitment, measurement, and adherence.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
64
Inclusion Criteria
  • Primary diagnosis of generalized anxiety disorder
  • Age 18 years or above
  • Being able to understand and speak Swedish without interpreter support
Exclusion Criteria
  • Psychosis, bipolar disorder, severe depressive symptoms, risk of suicid, substance use disorder, intellectual disability
  • Simultaneous psychological treatment
  • If pharmacological treatment, it needs to be stable prior to and during treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Penn State Worry Questionnaire - Measure of Symptom ChangeChange from baseline symptoms at 12 weeks

Penn State Worry Questionnaire, a self-reported symptom measure of worry. Scale ranges: 16-80 scores on a scale; higher values represent a worse outcome.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Liljeholmen Primary Health Care Center

🇸🇪

Stockholm, Sweden

Liljeholmen Primary Health Care Center
🇸🇪Stockholm, Sweden

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.